1 Alfred Hospital, Melbourne, VIC, Australia [email protected]
2 Ulm University Hospital, Ulm, Germany
3 Weill Cornell Medicine, New York, NY
Since publication of their article, Dr. Wei reports serving on the advisory boards for Roche, Pfizer, Agios, and Gilead; Dr. Döhner, receiving consulting fees from GEMoaB, Gilead, Berlin-Chemie, and Pfizer; and Dr. Roboz, receiving consulting fees from Amgen, Bristol Myers Squibb, GlaxoSmithKline, MEI Pharma, Mesoblast, and Roche/Genentech. No further potential conflict of interest relevant to this letter was reported.
